Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Measurement properties of anhedonia-related patient-reported outcome measures in depression-related populations: A COSMIN systematic review.

Created on 28 Oct 2026

Authors

Qilong Wang, Yile Cui, Zhijun Yao, Zhishui Wu, Xiaorong Zhao

Published in

Journal of affective disorders. Pages 122670. Oct 27, 2026. Epub Oct 27, 2026.

Abstract

Anhedonia is central to depressive disorders, but evidence on anhedonia-related patient-reported outcome measures (PROMs) has not been systematically synthesized using COSMIN.
We searched PubMed/MEDLINE, Embase, APA PsycInfo, Web of Science Core Collection, and the Cochrane Library from inception to 1 May 2026. COSMIN methods and PRISMA-COSMIN guidance informed the assessment of measurement properties, evidence certainty, and recommendations.
Twenty-five articles covering 28 instrument-level evaluations and 69 cohorts (58 adult, 11 adolescent) assessed 10 PROM families. Both English and Chinese adult DARS versions were Category A; other adult PROMs were Category B. For adolescents, the English Anhedonia Scale for Adolescents (ASA) was Category An under a developmental framework, whereas the Chinese ASA and DARS-Adolescent were Category B. Under strict DSM/ICD-defined clinical depression criteria, both DARS versions remained Category A, while both ASA versions were Category B. No PROM had high-certainty evidence across all nine measurement properties, and none was Category C.
Direct high-certainty clinical evidence was limited, and studies varied by population, language, setting, and instrument version.
DARS was the most comprehensively supported adult PROM. The English ASA is recommended for adolescents under a developmental framework; Chinese adolescent measures need further qualitative validation. Reliability, measurement error, cross-cultural validity, and meaningful-change thresholds require further study.
PROSPERO CRD420251142590.

PMID:
42946139
Bibliographic data and abstract were imported from PubMed on 28 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement